US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VYNE Therapeutics Inc.

0.9141

+0.02412.71%

Pre-market: 0.91820.0041+0.45%05:33 EDT

Volume:158.89K

Turnover:144.07K

Market Cap:15.23M

PE:-0.92

High:0.9300

Open:0.8900

Low:0.8900

Close:0.8900

Loading ...

Overview Company News Filings

VYNE Therapeutics Q4 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $84.000K Miss $140.000K Estimate

BRIEF-VYNE Therapeutics FY Revenue USD 501 Thousand

Vyne Therapeutics FY EPS From Cont Ops USD -0.93

THOMSON REUTERS

Vyne Therapeutics FY Net Income USD -39.834 Million

THOMSON REUTERS

VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update

EDSA: Raises $15 Million to Advance EB06…

Zacks Small Cap Research

Vyne Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview

TD Cowen Remains a Buy on VYNE Therapeutics (VYNE)

Vyne Therapeutics Price Target Maintained With a $5.75/Share by HC Wainwright & Co.

BRIEF-Vyne Therapeutics Initiates Phase 1B Trial Of Vyn202, A Novel Bd2-Selective Oral Bet Inhibitor, In Plaque Psoriasis

VYNE Therapeutics Receives Buy Rating: Promising Clinical Advances in Plaque Psoriasis Treatment

Vyne Therapeutics Initiates Phase 1B Trial of Vyn202, a Novel Bd2-Selective Oral Bet Inhibitor, in Plaque Psoriasis

THOMSON REUTERS

VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis

3 US Penny Stocks To Watch With Market Caps Over $20M

Simply Wall St.

VYNE Therapeutics (VYNE) Receives a Buy from TD Cowen

EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo…

Zacks Small Cap Research

BRIEF-Vyne Therapeutics Cash Runway Extends Into Second Half Of 2026

Vyne Therapeutics Inc - Cash Runway Extends Into Second Half of 2026

THOMSON REUTERS

VYNE Therapeutics (VYNE) Gets a Buy from BTIG

Buy Rating Justified for VYNE Therapeutics Due to Promising Repibresib Developments and Competitive Advantages

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VYNE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VYNE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VYNE\",,,,,undefined,":{"symbol":"VYNE","market":"US","secType":"STK","nameCN":"VYNE Therapeutics Inc.","latestPrice":0.9141,"timestamp":1750708800000,"preClose":0.89,"halted":0,"volume":158887,"hourTrading":{"tag":"盘前","latestPrice":0.9182,"preClose":0.9141,"latestTime":"05:33 EDT","volume":10,"amount":9.182,"timestamp":1750757613562},"delay":0,"floatShares":12039500,"shares":16664892,"eps":-0.990237,"marketStatus":"Pre-Mkt","change":0.0241,"latestTime":"06-24 07:58:10 EDT","open":0.89,"high":0.93,"low":0.89,"amount":144065.4804242,"amplitude":0.044944,"askPrice":1.07,"askSize":200,"bidPrice":0.9182,"bidSize":12,"shortable":3,"etf":0,"ttmEps":-0.990237,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1750771800000},"marketStatusCode":1,"adr":0,"listingDate":1516856400000,"exchange":"NASDAQ","adjPreClose":0.9141,"preHourTrading":{"tag":"盘前","latestPrice":0.9182,"preClose":0.9141,"latestTime":"05:33 EDT","volume":10,"amount":9.182,"timestamp":1750757613562},"postHourTrading":{"tag":"盘后","latestPrice":0.91,"preClose":0.9141,"latestTime":"19:29 EDT","volume":1117,"amount":1019.3771,"timestamp":1750721350856},"volumeRatio":0.6980171879201098,"impliedVol":3.8705,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VYNE\",,,,,undefined,":{"symbol":"VYNE","floatShares":12039500,"roa":"-38.36%","roe":"-66.15%","lyrEps":-0.935311,"volumeRatio":0.6980171879201098,"shares":16664892,"dividePrice":0,"high":0.93,"amplitude":0.044944,"preClose":0.89,"low":0.89,"week52Low":0.85,"pbRate":"0.35","psRate":"25.18","week52High":4.3,"institutionHeld":0,"latestPrice":0.9141,"committee":-0.886792,"eps":-0.990237,"divideRate":0,"volume":158887,"delay":0,"ttmEps":-0.990237,"open":0.89,"prevYearClose":3.35,"prevWeekClose":0.89,"prevMonthClose":0.95,"prevQuarterClose":1.58,"fiveDayClose":0.8994,"twentyDayClose":1,"sixtyDayClose":1.71},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VYNE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517529651","title":"VYNE Therapeutics Q4 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $84.000K Miss $140.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2517529651","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517529651?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:12","pubTimestamp":1741266768,"startTime":"0","endTime":"0","summary":"VYNE Therapeutics Q4 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $84.000K Miss $140.000K Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44163813/vyne-therapeutics-q4-2024-gaap-eps-0-28-beats-0-30-estimate-sales-84-000k-miss-140-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"VYNE Therapeutics Q4 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $84.000K Miss $140.000K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE"],"gpt_icon":0},{"id":"2517154140","title":"BRIEF-VYNE Therapeutics FY Revenue USD 501 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154140","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154140?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266046,"startTime":"0","endTime":"0","summary":"BRIEF-VYNE Therapeutics FY Revenue USD 501 Thousand\n\n\nMar 06 (Reuters) - VYNE Therapeutics FY net income USD -39.834 million.\n\nFY basic EPS USD -0.93\nFY EPS from cont ops USD -0.93","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nPLX8EA79E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE"],"gpt_icon":0},{"id":"2517154963","title":"Vyne Therapeutics FY EPS From Cont Ops USD -0.93","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154963?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nPLX8EA79E:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2517154950","title":"Vyne Therapeutics FY Net Income USD -39.834 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517154950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517154950?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nPLX8EA79E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2517547161","title":"VYNE Therapeutics Reports 2024 Fourth Quarter and Year-End Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2517547161","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517547161?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266000,"startTime":"0","endTime":"0","summary":"Repibresib gel (VYN201) Phase 2b vitiligo top-line results expected in mid-2025VYN202 Phase 1b psoriasis trial initiated with results anticipated by year-end 2025Expected cash runway into 2H 2026 BRID","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/06/3038147/0/en/VYNE-Therapeutics-Reports-2024-Fourth-Quarter-and-Year-End-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2516265401","title":"EDSA: Raises $15 Million to Advance EB06…","url":"https://stock-news.laohu8.com/highlight/detail?id=2516265401","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516265401?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:20","pubTimestamp":1741008000,"startTime":"0","endTime":"0","summary":"Edesa Biotech, Inc.  is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease that causes areas of the skin to lose color, with non-segmental vitiligo being characterized by patches appearing on both sides of the body. It is caused when pigment-producing cells  die or stop producing melanin as a result of an autoimmune disease, genetics, or a triggering event .A 2022 publication reported that the estimated prevalence of vitiligo patients in the U.S. is between 1.9 million and 2.8 million . This corresponds to a vitiligo market is projected to reach approximately $1 billion by 2030 . In support of this, the following two transactions show the potential for vitiligo treatments in development:. The company is continuing IND-enabling work in 2025 and has already received approval from Health Canada to conduct a Phase 2 trial. The","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/edsa-raises-15-million-advance-132000910.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","VYNE","INCY","BK4007","BK4139","BK4585","EDSA","BK4550","BK4532"],"gpt_icon":0},{"id":"2513724400","title":"Vyne Therapeutics Inc  expected to post a loss of 30 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724400","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513724400?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:19","pubTimestamp":1740406746,"startTime":"0","endTime":"0","summary":"Vyne Therapeutics Inc  expected to post a loss of30cents a share - Earnings Preview Vyne Therapeutics Inc VYNE.OQ VYNE.O is expected to show a rise in quarterly revenue when it reports  results on Feb","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL5N3PF1FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE"],"gpt_icon":0},{"id":"2512419784","title":"TD Cowen Remains a Buy on VYNE Therapeutics (VYNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2512419784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512419784?lang=en_us&edition=fundamental","pubTime":"2025-02-20 20:37","pubTimestamp":1740055039,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Stacy Ku maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $5.00. The company’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-remains-a-buy-on-vyne-therapeutics-vyne?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-remains-a-buy-on-vyne-therapeutics-vyne?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4207","BK4007","COWN","TD","BK4585","BK4127","VYNE"],"gpt_icon":0},{"id":"2512841444","title":"Vyne Therapeutics Price Target Maintained With a $5.75/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2512841444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512841444?lang=en_us&edition=fundamental","pubTime":"2025-02-20 00:22","pubTimestamp":1739982120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VYNE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 19, 2025 11:22 ET (16:22 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","VYNE"],"gpt_icon":0},{"id":"2512485353","title":"BRIEF-Vyne Therapeutics Initiates Phase 1B Trial Of Vyn202, A Novel Bd2-Selective Oral Bet Inhibitor, In Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485353","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512485353?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:02","pubTimestamp":1739977360,"startTime":"0","endTime":"0","summary":"BRIEF-Vyne Therapeutics Initiates Phase 1B Trial Of Vyn202, A Novel Bd2-Selective Oral Bet Inhibitor, In Plaque PsoriasisFeb 19 (Reuters) - Vyne Therapeutics Inc VYNE.O:VYNE THERAPEUTICS INITIATES PHA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA53TT1V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2512485899","title":"VYNE Therapeutics Receives Buy Rating: Promising Clinical Advances in Plaque Psoriasis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485899","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512485899?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:45","pubTimestamp":1739976312,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $5.7...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vyne-therapeutics-receives-buy-rating-promising-clinical-advances-in-plaque-psoriasis-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vyne-therapeutics-receives-buy-rating-promising-clinical-advances-in-plaque-psoriasis-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE"],"gpt_icon":0},{"id":"2512101621","title":"Vyne Therapeutics Initiates Phase 1B Trial of Vyn202, a Novel Bd2-Selective Oral Bet Inhibitor, in Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2512101621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512101621?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nTUA53TT1V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2512839104","title":"VYNE Therapeutics Initiates Phase 1b Trial of VYN202, a Novel BD2-Selective Oral BET Inhibitor, in Plaque Psoriasis","url":"https://stock-news.laohu8.com/highlight/detail?id=2512839104","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512839104?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:00","pubTimestamp":1739970000,"startTime":"0","endTime":"0","summary":"Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasis Top-line data from the 12-week double-blind trial expected by year-end 2025 Phase 1b trial designe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/19/3028700/0/en/VYNE-Therapeutics-Initiates-Phase-1b-Trial-of-VYN202-a-Novel-BD2-Selective-Oral-BET-Inhibitor-in-Plaque-Psoriasis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VYNE","BK4007","IBD"],"gpt_icon":0},{"id":"2511854019","title":"3 US Penny Stocks To Watch With Market Caps Over $20M","url":"https://stock-news.laohu8.com/highlight/detail?id=2511854019","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511854019?lang=en_us&edition=fundamental","pubTime":"2025-02-13 21:11","pubTimestamp":1739452278,"startTime":"0","endTime":"0","summary":"As U.S. markets face pressure from rising yields and inflation concerns, investors are re-evaluating their strategies to navigate these challenging conditions. While the term \"penny stocks\" may seem outdated, it still signifies smaller or emerging companies that could offer substantial growth potential. By focusing on those with strong financial foundations, investors can uncover opportunities in this segment of the market that might be overlooked by others.Overview: B.O.S. Better Online Solutions Ltd. offers intelligent robotics, RFID, and supply chain solutions to enterprises globally, with a market cap of $21.72 million.Overview: VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing proprietary therapeutics for treating immuno-inflammatory conditions, with a market cap of $36.44 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-us-penny-stocks-watch-131118187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BOSC","ZEPP","BABB","SB","BK4021","BK4157","VYNE","BK4213","BK4563","BK4209","PVL","PHX","BK4020"],"gpt_icon":0},{"id":"2507495243","title":"VYNE Therapeutics (VYNE) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2507495243","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507495243?lang=en_us&edition=fundamental","pubTime":"2025-01-31 20:46","pubTimestamp":1738327605,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Stacy Ku maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report) today and set a price target of $5.00. The company’...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vyne-therapeutics-vyne-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vyne-therapeutics-vyne-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","COWN","TD","BK4566","BK4007","VYNE","BK4207","BK4585"],"gpt_icon":0},{"id":"2505784177","title":"EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo…","url":"https://stock-news.laohu8.com/highlight/detail?id=2505784177","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505784177?lang=en_us&edition=fundamental","pubTime":"2025-01-22 19:23","pubTimestamp":1737544980,"startTime":"0","endTime":"0","summary":"Edesa Biotech, Inc.  is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease that causes areas of the skin to lose color, with non-segmental vitiligo being characterized by patches appearing on both sides of the body. It is caused when pigment-producing cells  die or stop producing melanin as a result of an autoimmune disease, genetics, or a triggering event .A 2022 publication reported that the estimated prevalence of vitiligo patients in the U.S. is between 1.9 million and 2.8 million . This corresponds to a vitiligo market is projected to reach approximately $1 billion by 2030 . In support of this, the following two transactions show the potential for vitiligo treatments in development:. The company is continuing IND-enabling work in 2025 and has already received approval from Health Canada to conduct a Phase 2 tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/edsa-ind-expected-2025-eb06-112300368.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SIF","USAW.SI","ARDS","PSQ","BK4007","NQmain","TSYW.SI","USJW.SI","VYNE","BK4187","MNQmain","TQQQ","BK4550","BK4532","BK4585","EDSA","INCY","BK4588","NVIW.SI","SOC","BK4139",".IXIC","QID","QLD","BK4213","SQQQ"],"gpt_icon":1},{"id":"2503021693","title":"BRIEF-Vyne Therapeutics Cash Runway Extends Into Second Half Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2503021693","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503021693?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:52","pubTimestamp":1736776335,"startTime":"0","endTime":"0","summary":"BRIEF-Vyne Therapeutics Cash Runway Extends Into Second Half Of 2026Jan 13 (Reuters) - Vyne Therapeutics Inc VYNE.O:VYNE THERAPEUTICS INC - CASH RUNWAY EXTENDS INTO SECOND HALF OF 2026Further company coverage: VYNE.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O913K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VYNE"],"gpt_icon":0},{"id":"2503306452","title":"Vyne Therapeutics Inc - Cash Runway Extends Into Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2503306452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503306452?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:56","pubTimestamp":1736772976,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O913K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2501790155","title":"VYNE Therapeutics (VYNE) Gets a Buy from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2501790155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501790155?lang=en_us&edition=fundamental","pubTime":"2025-01-08 14:15","pubTimestamp":1736316922,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on VYNE Therapeutics (VYNE – Research Report), with a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vyne-therapeutics-vyne-gets-a-buy-from-btig?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vyne-therapeutics-vyne-gets-a-buy-from-btig?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE","BK4007"],"gpt_icon":0},{"id":"2501255244","title":"Buy Rating Justified for VYNE Therapeutics Due to Promising Repibresib Developments and Competitive Advantages","url":"https://stock-news.laohu8.com/highlight/detail?id=2501255244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501255244?lang=en_us&edition=fundamental","pubTime":"2025-01-06 23:15","pubTimestamp":1736176519,"startTime":"0","endTime":"0","summary":"VYNE Therapeutics (VYNE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Rami Katkhuda from...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-justified-for-vyne-therapeutics-due-to-promising-repibresib-developments-and-competitive-advantages?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-justified-for-vyne-therapeutics-due-to-promising-repibresib-developments-and-competitive-advantages?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VYNE"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VYNE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"VYNE","fiscalQuarterEnding":"2025/03","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.2},{"market":"US","date":"2025-03-06","symbol":"VYNE","fiscalQuarterEnding":"2024/12","expectedEps":-0.31,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"pre","actualEps":-0.28},{"market":"US","date":"2024-11-07","symbol":"VYNE","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2024-08-14","symbol":"VYNE","fiscalQuarterEnding":"2024/06","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.22},{"market":"US","date":"2024-05-09","symbol":"VYNE","fiscalQuarterEnding":"2024/03","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VYNE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VYNE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1732161600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VYNE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VYNE","date":"2025-06-20","current":-0.371402,"percent":0.906325,"low":-3.012005,"twenty":-1.131159,"median":-0.784338,"eighty":-0.437293,"high":-0.209883,"avg":-0.842916,"sd":0.444655,"marketCap":15671664},"quantilePoints":[{"date":"2020-06-26","current":-2.440282,"twenty":-15.84755,"median":-6.425676,"eighty":-2.729662,"marketCap":293338978},{"date":"2020-07-02","current":-2.356615,"twenty":-15.789417,"median":-4.395709,"eighty":-2.725462,"marketCap":283281641},{"date":"2020-07-10","current":-2.328726,"twenty":-15.668756,"median":-4.218616,"eighty":-2.716228,"marketCap":279929195},{"date":"2020-07-17","current":-2.510004,"twenty":-15.631022,"median":-4.180668,"eighty":-2.707537,"marketCap":301720092},{"date":"2020-07-24","current":-2.286893,"twenty":-15.559608,"median":-4.128748,"eighty":-2.704817,"marketCap":274900527},{"date":"2020-07-31","current":-2.245059,"twenty":-15.521402,"median":-4.048131,"eighty":-2.698227,"marketCap":269871860},{"date":"2020-08-07","current":-1.008064,"twenty":-15.416119,"median":-3.978275,"eighty":-2.689761,"marketCap":270820319},{"date":"2020-08-14","current":-1.004943,"twenty":-15.335927,"median":-3.946651,"eighty":-2.685289,"marketCap":269981868},{"date":"2020-08-21","current":-0.948766,"twenty":-15.260479,"median":-3.927677,"eighty":-2.682509,"marketCap":254889713},{"date":"2020-08-28","current":-0.923798,"twenty":-15.146631,"median":-3.901334,"eighty":-2.671563,"marketCap":248182088},{"date":"2020-09-04","current":-0.842654,"twenty":-15.10232,"median":-3.86791,"eighty":-2.657906,"marketCap":226382311},{"date":"2020-09-11","current":-0.942524,"twenty":-15.031719,"median":-3.823319,"eighty":-2.64737,"marketCap":253212808},{"date":"2020-09-18","current":-1.142264,"twenty":-14.989672,"median":-3.793665,"eighty":-2.637635,"marketCap":306873800},{"date":"2020-09-25","current":-0.948766,"twenty":-14.924212,"median":-3.763233,"eighty":-2.626973,"marketCap":254889713},{"date":"2020-10-02","current":-1.004943,"twenty":-14.88239,"median":-3.709443,"eighty":-2.586391,"marketCap":269981868},{"date":"2020-10-09","current":-1.167232,"twenty":-14.866007,"median":-3.670217,"eighty":-2.572592,"marketCap":313581424},{"date":"2020-10-16","current":-1.22965,"twenty":-14.809411,"median":-3.64701,"eighty":-2.566086,"marketCap":330350484},{"date":"2020-10-23","current":-1.173473,"twenty":-14.782583,"median":-3.584263,"eighty":-2.551935,"marketCap":315258329},{"date":"2020-10-30","current":-0.998701,"twenty":-14.749752,"median":-3.491108,"eighty":-2.538031,"marketCap":268304960},{"date":"2020-11-06","current":-1.040671,"twenty":-14.674813,"median":-3.446314,"eighty":-2.525469,"marketCap":281196643},{"date":"2020-11-13","current":-1.049991,"twenty":-14.554638,"median":-3.422836,"eighty":-2.516299,"marketCap":283714821},{"date":"2020-11-20","current":-1.037565,"twenty":-14.39517,"median":-3.396092,"eighty":-2.505874,"marketCap":280357249},{"date":"2020-11-27","current":-1.06863,"twenty":-14.323371,"median":-3.372894,"eighty":-2.49309,"marketCap":288751178},{"date":"2020-12-04","current":-1.056204,"twenty":-14.113343,"median":-3.341543,"eighty":-2.477779,"marketCap":285393609},{"date":"2020-12-11","current":-1.056204,"twenty":-14.008856,"median":-3.315409,"eighty":-2.467235,"marketCap":285393609},{"date":"2020-12-18","current":-1.11212,"twenty":-13.910205,"median":-3.284302,"eighty":-2.443983,"marketCap":300502680},{"date":"2020-12-24","current":-1.099694,"twenty":-13.65471,"median":-3.265694,"eighty":-2.427721,"marketCap":297145110},{"date":"2020-12-31","current":-0.981648,"twenty":-13.013323,"median":-3.250235,"eighty":-2.413195,"marketCap":265248175},{"date":"2021-01-08","current":-1.018926,"twenty":-12.35855,"median":-3.213688,"eighty":-2.40737,"marketCap":275320892},{"date":"2021-01-15","current":-1.037565,"twenty":-12.191081,"median":-3.200919,"eighty":-2.393322,"marketCap":280357249},{"date":"2021-01-22","current":-1.168037,"twenty":-12.109055,"median":-3.14863,"eighty":-2.382446,"marketCap":315611754},{"date":"2021-01-29","current":-1.384759,"twenty":-11.862978,"median":-3.136459,"eighty":-2.365482,"marketCap":374171655},{"date":"2021-02-05","current":-1.923277,"twenty":-11.661331,"median":-3.106342,"eighty":-2.356615,"marketCap":519682856},{"date":"2021-02-12","current":-2.012457,"twenty":-11.275895,"median":-3.096642,"eighty":-2.336596,"marketCap":543779945},{"date":"2021-02-19","current":-1.633604,"twenty":-11.165759,"median":-3.083564,"eighty":-2.328726,"marketCap":441411227},{"date":"2021-02-26","current":-1.417056,"twenty":-10.93677,"median":-3.068303,"eighty":-2.300906,"marketCap":382898574},{"date":"2021-03-05","current":-1.341635,"twenty":-10.594996,"median":-3.059947,"eighty":-2.292423,"marketCap":342878872},{"date":"2021-03-12","current":-1.484233,"twenty":-10.48001,"median":-3.038779,"eighty":-2.284444,"marketCap":379322586},{"date":"2021-03-19","current":-1.570596,"twenty":-10.302539,"median":-3.028301,"eighty":-2.262253,"marketCap":401394131},{"date":"2021-03-26","current":-1.375778,"twenty":-10.239551,"median":-3.02295,"eighty":-2.241171,"marketCap":351604833},{"date":"2021-04-01","current":-1.389837,"twenty":-10.193445,"median":-3.017822,"eighty":-2.223736,"marketCap":355197875},{"date":"2021-04-09","current":-1.206065,"twenty":-10.009739,"median":-3.013643,"eighty":-2.182502,"marketCap":308231681},{"date":"2021-04-16","current":-1.073509,"twenty":-9.848225,"median":-3.01141,"eighty":-2.139594,"marketCap":274354429},{"date":"2021-04-23","current":-1.040369,"twenty":-9.715151,"median":-3.004507,"eighty":-2.096665,"marketCap":265885114},{"date":"2021-04-30","current":-0.992167,"twenty":-9.57099,"median":-2.993653,"eighty":-2.057047,"marketCap":253566111},{"date":"2021-05-07","current":-0.790781,"twenty":-9.464437,"median":-2.988527,"eighty":-2.019718,"marketCap":186533330},{"date":"2021-05-14","current":-0.768996,"twenty":-9.307407,"median":-2.973993,"eighty":-2.016125,"marketCap":181394672},{"date":"2021-05-21","current":-0.797316,"twenty":-9.088041,"median":-2.961564,"eighty":-2.00909,"marketCap":188074929},{"date":"2021-05-28","current":-0.860492,"twenty":-9.034767,"median":-2.956664,"eighty":-1.983332,"marketCap":202977041},{"date":"2021-06-04","current":-0.83435,"twenty":-8.915696,"median":-2.952644,"eighty":-1.958936,"marketCap":196810648},{"date":"2021-06-11","current":-0.869219,"twenty":-8.847055,"median":-2.942392,"eighty":-1.931817,"marketCap":205035664},{"date":"2021-06-18","current":-0.792971,"twenty":-8.77346,"median":-2.932241,"eighty":-1.915649,"marketCap":187050079},{"date":"2021-06-25","current":-0.814756,"twenty":-8.724832,"median":-2.931017,"eighty":-1.830504,"marketCap":192188819},{"date":"2021-07-02","current":-0.712367,"twenty":-8.679459,"median":-2.922421,"eighty":-1.719354,"marketCap":168036745},{"date":"2021-07-09","current":-0.675333,"twenty":-8.632472,"median":-2.91025,"eighty":-1.696044,"marketCap":159300892},{"date":"2021-07-16","current":-0.586015,"twenty":-8.613657,"median":-2.901383,"eighty":-1.634928,"marketCap":138232064},{"date":"2021-07-23","current":-0.588193,"twenty":-8.536797,"median":-2.889685,"eighty":-1.57294,"marketCap":138745938},{"date":"2021-07-30","current":-0.588193,"twenty":-8.353588,"median":-2.873597,"eighty":-1.52256,"marketCap":138745938},{"date":"2021-08-06","current":-0.568587,"twenty":-8.178118,"median":-2.866758,"eighty":-1.484233,"marketCap":134121073},{"date":"2021-08-13","current":-1.037593,"twenty":-8.08413,"median":-2.857125,"eighty":-1.418198,"marketCap":91691068},{"date":"2021-08-20","current":-0.833572,"twenty":-7.903737,"median":-2.845136,"eighty":-1.391042,"marketCap":73661925},{"date":"2021-08-27","current":-0.961814,"twenty":-7.719277,"median":-2.841842,"eighty":-1.376983,"marketCap":84994530},{"date":"2021-09-03","current":-0.973472,"twenty":-7.614348,"median":-2.832842,"eighty":-1.344447,"marketCap":86024764},{"date":"2021-09-10","current":-0.91518,"twenty":-7.505957,"median":-2.828213,"eighty":-1.290219,"marketCap":80873582},{"date":"2021-09-17","current":-0.91518,"twenty":-7.410428,"median":-2.823772,"eighty":-1.251811,"marketCap":80873582},{"date":"2021-09-24","current":-0.868547,"twenty":-7.337406,"median":-2.820901,"eighty":-1.204683,"marketCap":76752635},{"date":"2021-10-01","current":-0.816084,"twenty":-7.28943,"median":-2.813137,"eighty":-1.182212,"marketCap":72116569},{"date":"2021-10-08","current":-0.722818,"twenty":-7.248677,"median":-2.803676,"eighty":-1.168357,"marketCap":63874677},{"date":"2021-10-15","current":-0.711159,"twenty":-7.059479,"median":-2.801189,"eighty":-1.153641,"marketCap":62844439},{"date":"2021-10-22","current":-0.664526,"twenty":-7.031634,"median":-2.794238,"eighty":-1.136022,"marketCap":58723492},{"date":"2021-10-29","current":-0.781109,"twenty":-6.971721,"median":-2.791095,"eighty":-1.130204,"marketCap":69025859},{"date":"2021-11-05","current":-0.798597,"twenty":-6.934155,"median":-2.784895,"eighty":-1.114191,"marketCap":70571215},{"date":"2021-11-12","current":-0.819087,"twenty":-6.887177,"median":-2.778299,"eighty":-1.101481,"marketCap":69573268},{"date":"2021-11-19","current":-0.674172,"twenty":-6.845688,"median":-2.776816,"eighty":-1.093481,"marketCap":57264150},{"date":"2021-11-26","current":-0.648969,"twenty":-6.786853,"median":-2.76863,"eighty":-1.081055,"marketCap":55123435},{"date":"2021-12-03","current":-0.573487,"twenty":-6.736796,"median":-2.758037,"eighty":-1.073603,"marketCap":48711989},{"date":"2021-12-10","current":-0.945101,"twenty":-6.637611,"median":-2.748976,"eighty":-1.067361,"marketCap":80276847},{"date":"2021-12-17","current":-0.680472,"twenty":-6.515916,"median":-2.738843,"eighty":-1.056204,"marketCap":57799329},{"date":"2021-12-23","current":-0.705675,"twenty":-6.447458,"median":-2.729662,"eighty":-1.05469,"marketCap":59940044},{"date":"2021-12-31","current":-0.642668,"twenty":-4.394445,"median":-2.724423,"eighty":-1.0476,"marketCap":54588256},{"date":"2022-01-07","current":-0.642668,"twenty":-4.232531,"median":-2.716799,"eighty":-1.039814,"marketCap":54588256},{"date":"2022-01-14","current":-0.432919,"twenty":-4.186992,"median":-2.707537,"eighty":-1.037565,"marketCap":36772148},{"date":"2022-01-21","current":-0.396942,"twenty":-4.155847,"median":-2.705387,"eighty":-1.031352,"marketCap":33716273},{"date":"2022-01-28","current":-0.35624,"twenty":-4.059051,"median":-2.698383,"eighty":-1.02991,"marketCap":30259017},{"date":"2022-02-04","current":-0.355988,"twenty":-3.997265,"median":-2.694472,"eighty":-1.024845,"marketCap":30237610},{"date":"2022-02-11","current":-0.321838,"twenty":-3.955664,"median":-2.686908,"eighty":-1.018926,"marketCap":27336940},{"date":"2022-02-18","current":-0.345529,"twenty":-3.935196,"median":-2.682509,"eighty":-1.011185,"marketCap":29349215},{"date":"2022-02-25","current":-0.338409,"twenty":-3.909968,"median":-2.679178,"eighty":-1.010595,"marketCap":28744462},{"date":"2022-03-04","current":-0.318688,"twenty":-3.877127,"median":-2.665675,"eighty":-1.006189,"marketCap":27069351},{"date":"2022-03-11","current":-0.37804,"twenty":-3.846508,"median":-2.648422,"eighty":-0.992459,"marketCap":32110738},{"date":"2022-03-18","current":-0.557361,"twenty":-3.807602,"median":-2.641684,"eighty":-0.987315,"marketCap":40870705},{"date":"2022-03-25","current":-0.56785,"twenty":-3.768129,"median":-2.630148,"eighty":-0.978135,"marketCap":41639887},{"date":"2022-04-01","current":-0.557755,"twenty":-3.725227,"median":-2.586391,"eighty":-0.95579,"marketCap":40899622},{"date":"2022-04-08","current":-0.466741,"twenty":-3.681738,"median":-2.575153,"eighty":-0.944586,"marketCap":34225674},{"date":"2022-04-14","current":-0.417449,"twenty":-3.661837,"median":-2.570012,"eighty":-0.930013,"marketCap":30611100},{"date":"2022-04-22","current":-0.361689,"twenty":-3.62775,"median":-2.559572,"eighty":-0.924291,"marketCap":26522294},{"date":"2022-04-29","current":-0.331246,"twenty":-3.517056,"median":-2.544777,"eighty":-0.91518,"marketCap":24289932},{"date":"2022-05-06","current":-0.32257,"twenty":-3.464103,"median":-2.537327,"eighty":-0.905139,"marketCap":23653770},{"date":"2022-05-13","current":-0.47919,"twenty":-3.429547,"median":-2.519013,"eighty":-0.893063,"marketCap":23053362},{"date":"2022-05-20","current":-0.481598,"twenty":-3.412794,"median":-2.509924,"eighty":-0.886285,"marketCap":23169179},{"date":"2022-05-27","current":-0.455959,"twenty":-3.386705,"median":-2.494508,"eighty":-0.878443,"marketCap":21935728},{"date":"2022-06-03","current":-0.536245,"twenty":-3.358585,"median":-2.485189,"eighty":-0.868547,"marketCap":25798223},{"date":"2022-06-10","current":-0.579578,"twenty":-3.327529,"median":-2.469292,"eighty":-0.862718,"marketCap":27882929},{"date":"2022-06-17","current":-0.613385,"twenty":-3.30169,"median":-2.453216,"eighty":-0.858028,"marketCap":29509346},{"date":"2022-06-24","current":-0.602539,"twenty":-3.270101,"median":-2.43376,"eighty":-0.843636,"marketCap":28987570},{"date":"2022-07-01","current":-0.526619,"twenty":-3.253695,"median":-2.414398,"eighty":-0.834039,"marketCap":25335136},{"date":"2022-07-08","current":-0.586512,"twenty":-3.219634,"median":-2.411769,"eighty":-0.826801,"marketCap":28216500},{"date":"2022-07-15","current":-0.542165,"twenty":-3.20842,"median":-2.398449,"eighty":-0.817886,"marketCap":26083016},{"date":"2022-07-22","current":-0.572292,"twenty":-3.152577,"median":-2.382446,"eighty":-0.810334,"marketCap":27532396},{"date":"2022-07-29","current":-0.520715,"twenty":-3.137014,"median":-2.37056,"eighty":-0.805388,"marketCap":25051057},{"date":"2022-08-05","current":-0.500228,"twenty":-3.11322,"median":-2.356615,"eighty":-0.792971,"marketCap":24065482},{"date":"2022-08-12","current":-0.499189,"twenty":-3.098806,"median":-2.338463,"eighty":-0.791973,"marketCap":18300754},{"date":"2022-08-19","current":-0.506467,"twenty":-3.083138,"median":-2.328726,"eighty":-0.782079,"marketCap":18567580},{"date":"2022-08-26","current":-0.51327,"twenty":-3.068199,"median":-2.300837,"eighty":-0.775312,"marketCap":18817004},{"date":"2022-09-02","current":-0.459633,"twenty":-3.060085,"median":-2.292423,"eighty":-0.76707,"marketCap":16850614},{"date":"2022-09-09","current":-0.458842,"twenty":-3.044121,"median":-2.28687,"eighty":-0.757108,"marketCap":16821611},{"date":"2022-09-16","current":-0.433527,"twenty":-3.031386,"median":-2.275251,"eighty":-0.740528,"marketCap":15893524},{"date":"2022-09-23","current":-0.379731,"twenty":-3.024093,"median":-2.242296,"eighty":-0.734476,"marketCap":13921333},{"date":"2022-09-30","current":-0.352992,"twenty":-3.017822,"median":-2.223736,"eighty":-0.724046,"marketCap":12941039},{"date":"2022-10-07","current":-0.379731,"twenty":-3.013643,"median":-2.180807,"eighty":-0.71514,"marketCap":13921333},{"date":"2022-10-14","current":-0.383687,"twenty":-3.01142,"median":-2.137877,"eighty":-0.703155,"marketCap":14066348},{"date":"2022-10-21","current":-0.379731,"twenty":-3.004923,"median":-2.094948,"eighty":-0.687415,"marketCap":13921333},{"date":"2022-10-28","current":-0.397927,"twenty":-2.994938,"median":-2.056158,"eighty":-0.680472,"marketCap":14588398},{"date":"2022-11-04","current":-0.440172,"twenty":-2.988713,"median":-2.018082,"eighty":-0.673765,"marketCap":16137145},{"date":"2022-11-11","current":-0.630717,"twenty":-2.9754,"median":-2.015737,"eighty":-0.663292,"marketCap":15663868},{"date":"2022-11-18","current":-0.54402,"twenty":-2.96311,"median":-2.00909,"eighty":-0.65275,"marketCap":13510737},{"date":"2022-11-25","current":-0.535374,"twenty":-2.956803,"median":-1.983332,"eighty":-0.647028,"marketCap":13296004},{"date":"2022-12-02","current":-0.531401,"twenty":-2.952644,"median":-1.957575,"eighty":-0.64014,"marketCap":13197343},{"date":"2022-12-09","current":-0.485716,"twenty":-2.944274,"median":-1.931817,"eighty":-0.630067,"marketCap":12062745},{"date":"2022-12-16","current":-0.394695,"twenty":-2.934195,"median":-1.915649,"eighty":-0.62345,"marketCap":9802248},{"date":"2022-12-23","current":-0.277385,"twenty":-2.931175,"median":-1.828787,"eighty":-0.609107,"marketCap":6888851},{"date":"2022-12-30","current":-0.350528,"twenty":-2.922421,"median":-1.720438,"eighty":-0.602539,"marketCap":8705370},{"date":"2023-01-06","current":-0.528129,"twenty":-2.914318,"median":-1.701179,"eighty":-0.599086,"marketCap":13116093},{"date":"2023-01-13","current":-0.625812,"twenty":-2.901383,"median":-1.640222,"eighty":-0.598214,"marketCap":15542051},{"date":"2023-01-20","current":-0.537474,"twenty":-2.89628,"median":-1.593714,"eighty":-0.592596,"marketCap":13348179},{"date":"2023-01-27","current":-0.595898,"twenty":-2.881945,"median":-1.553241,"eighty":-0.588193,"marketCap":14799133},{"date":"2023-02-03","current":-0.596599,"twenty":-2.870663,"median":-1.486242,"eighty":-0.588133,"marketCap":14816544},{"date":"2023-02-10","current":-0.526768,"twenty":-2.863706,"median":-1.42398,"eighty":-0.586313,"marketCap":13082276},{"date":"2023-02-17","current":-0.468762,"twenty":-2.848902,"median":-1.399461,"eighty":-0.584214,"marketCap":11641708},{"date":"2023-02-24","current":-0.441736,"twenty":-2.844954,"median":-1.384759,"eighty":-0.580557,"marketCap":10970522},{"date":"2023-03-03","current":-0.407221,"twenty":-2.839687,"median":-1.363727,"eighty":-0.573877,"marketCap":10113328},{"date":"2023-03-10","current":-0.365678,"twenty":-2.830059,"median":-1.323559,"eighty":-0.571681,"marketCap":8487391},{"date":"2023-03-17","current":-0.351602,"twenty":-2.824263,"median":-1.26465,"eighty":-0.558885,"marketCap":8160680},{"date":"2023-03-24","current":-0.36426,"twenty":-2.823053,"median":-1.206065,"eighty":-0.555526,"marketCap":8454464},{"date":"2023-03-31","current":-0.433174,"twenty":-2.82256,"median":-1.197734,"eighty":-0.554288,"marketCap":10053957},{"date":"2023-04-06","current":-0.362853,"twenty":-2.813783,"median":-1.176594,"eighty":-0.551929,"marketCap":8421821},{"date":"2023-04-14","current":-0.39378,"twenty":-2.803676,"median":-1.167232,"eighty":-0.543935,"marketCap":9139635},{"date":"2023-04-21","current":-0.616007,"twenty":-2.802456,"median":-1.142264,"eighty":-0.542237,"marketCap":14297511},{"date":"2023-04-28","current":-0.749615,"twenty":-2.795658,"median":-1.130759,"eighty":-0.542237,"marketCap":17398569},{"date":"2023-05-05","current":-1.030897,"twenty":-2.792533,"median":-1.12978,"eighty":-0.542237,"marketCap":23927113},{"date":"2023-05-12","current":-0.857909,"twenty":-2.785189,"median":-1.11212,"eighty":-0.542237,"marketCap":19912059},{"date":"2023-05-19","current":-0.66061,"twenty":-2.784895,"median":-1.099694,"eighty":-0.542237,"marketCap":22131764},{"date":"2023-05-26","current":-0.689368,"twenty":-2.784617,"median":-1.093481,"eighty":-0.542237,"marketCap":23095208},{"date":"2023-06-02","current":-0.59563,"twenty":-2.783005,"median":-1.081055,"eighty":-0.542237,"marketCap":19954783},{"date":"2023-06-09","current":-0.56535,"twenty":-2.783005,"median":-1.073603,"eighty":-0.542237,"marketCap":18940360},{"date":"2023-06-16","current":-0.46547,"twenty":-2.778299,"median":-1.067361,"eighty":-0.537009,"marketCap":15594172},{"date":"2023-06-23","current":-0.471631,"twenty":-2.778299,"median":-1.056204,"eighty":-0.535561,"marketCap":15800590},{"date":"2023-06-30","current":-0.408153,"twenty":-2.778299,"median":-1.056204,"eighty":-0.530279,"marketCap":13673933},{"date":"2023-07-07","current":-0.408153,"twenty":-2.778299,"median":-1.049991,"eighty":-0.527943,"marketCap":13673933},{"date":"2023-07-14","current":-0.400351,"twenty":-2.767963,"median":-1.040671,"eighty":-0.525138,"marketCap":13412558},{"date":"2023-07-21","current":-0.424752,"twenty":-2.753666,"median":-1.037565,"eighty":-0.517797,"marketCap":14230050},{"date":"2023-07-28","current":-0.367142,"twenty":-2.7462,"median":-1.031352,"eighty":-0.513338,"marketCap":12299997},{"date":"2023-08-04","current":-0.520444,"twenty":-2.72702,"median":-1.02991,"eighty":-0.509117,"marketCap":17435901},{"date":"2023-08-11","current":-0.526302,"twenty":-2.711868,"median":-1.025139,"eighty":-0.506968,"marketCap":17632177},{"date":"2023-08-18","current":-0.441268,"twenty":-2.705547,"median":-1.018926,"eighty":-0.506341,"marketCap":15481463},{"date":"2023-08-25","current":-0.395459,"twenty":-2.698363,"median":-1.012713,"eighty":-0.500653,"marketCap":13874277},{"date":"2023-09-01","current":-0.406677,"twenty":-2.686058,"median":-1.011185,"eighty":-0.495076,"marketCap":14267873},{"date":"2023-09-08","current":-0.410417,"twenty":-2.679178,"median":-1.0065,"eighty":-0.490065,"marketCap":14399072},{"date":"2023-09-15","current":-0.361803,"twenty":-2.663656,"median":-0.998701,"eighty":-0.486015,"marketCap":12693487},{"date":"2023-09-22","current":-0.319733,"twenty":-2.64737,"median":-0.99096,"eighty":-0.481428,"marketCap":11217500},{"date":"2023-09-29","current":-0.374891,"twenty":-2.6344,"median":-0.979975,"eighty":-0.479527,"marketCap":13152683},{"date":"2023-10-06","current":-0.331886,"twenty":-2.586391,"median":-0.961814,"eighty":-0.473155,"marketCap":11643897},{"date":"2023-10-13","current":-0.2599,"twenty":-2.570012,"median":-0.948766,"eighty":-0.470551,"marketCap":9118319},{"date":"2023-10-20","current":-0.257095,"twenty":-2.562442,"median":-0.93004,"eighty":-0.466123,"marketCap":9019920},{"date":"2023-10-27","current":-0.213155,"twenty":-2.547669,"median":-0.926839,"eighty":-0.465203,"marketCap":7478333},{"date":"2023-11-03","current":-0.284207,"twenty":-2.537327,"median":-0.916368,"eighty":-0.459796,"marketCap":9971111},{"date":"2023-11-10","current":-0.284674,"twenty":-2.522616,"median":-0.909563,"eighty":-0.457732,"marketCap":9987511},{"date":"2023-11-17","current":-1.724678,"twenty":-2.512522,"median":-0.905115,"eighty":-0.457233,"marketCap":55550149},{"date":"2023-11-24","current":-1.737678,"twenty":-2.499195,"median":-0.905115,"eighty":-0.457233,"marketCap":55968869},{"date":"2023-12-01","current":-1.434343,"twenty":-2.488262,"median":-0.905115,"eighty":-0.457233,"marketCap":46198742},{"date":"2023-12-08","current":-1.404009,"twenty":-2.474488,"median":-0.905156,"eighty":-0.457318,"marketCap":45221729},{"date":"2023-12-15","current":-1.200341,"twenty":-2.467235,"median":-0.905156,"eighty":-0.457318,"marketCap":38661787},{"date":"2023-12-22","current":-1.100674,"twenty":-2.442132,"median":-0.905156,"eighty":-0.457318,"marketCap":35451602},{"date":"2023-12-29","current":-1.08334,"twenty":-2.443983,"median":-0.905115,"eighty":-0.457233,"marketCap":34893310},{"date":"2024-01-05","current":-0.936006,"twenty":-2.428413,"median":-0.905073,"eighty":-0.457148,"marketCap":30147819},{"date":"2024-01-12","current":-0.918673,"twenty":-2.412393,"median":-0.905073,"eighty":-0.457148,"marketCap":29589526},{"date":"2024-01-19","current":-0.810339,"twenty":-2.404358,"median":-0.892927,"eighty":-0.457063,"marketCap":26100195},{"date":"2024-01-26","current":-0.771338,"twenty":-2.387059,"median":-0.888825,"eighty":-0.457148,"marketCap":24844036},{"date":"2024-02-02","current":-0.788672,"twenty":-2.37056,"median":-0.880205,"eighty":-0.457148,"marketCap":25402329},{"date":"2024-02-09","current":-0.927339,"twenty":-2.356615,"median":-0.880205,"eighty":-0.457148,"marketCap":29868673},{"date":"2024-02-16","current":-0.936006,"twenty":-2.337219,"median":-0.879672,"eighty":-0.457148,"marketCap":30147819},{"date":"2024-02-23","current":-0.940339,"twenty":-2.328726,"median":-0.879672,"eighty":-0.457148,"marketCap":30287393},{"date":"2024-03-01","current":-0.96634,"twenty":-2.300906,"median":-0.879938,"eighty":-0.457233,"marketCap":31124832},{"date":"2024-03-08","current":-1.149635,"twenty":-2.292423,"median":-0.879938,"eighty":-0.457233,"marketCap":32709420},{"date":"2024-03-15","current":-1.020797,"twenty":-2.28505,"median":-0.879938,"eighty":-0.457233,"marketCap":29043709},{"date":"2024-03-22","current":-1.154591,"twenty":-2.265503,"median":-0.879938,"eighty":-0.457233,"marketCap":32850409},{"date":"2024-03-28","current":-1.466776,"twenty":-2.243401,"median":-0.879938,"eighty":-0.457233,"marketCap":41732708},{"date":"2024-04-05","current":-1.407312,"twenty":-2.221047,"median":-0.879672,"eighty":-0.457148,"marketCap":40040841},{"date":"2024-04-12","current":-1.486597,"twenty":-2.180807,"median":-0.879672,"eighty":-0.457148,"marketCap":42296664},{"date":"2024-04-19","current":-1.139725,"twenty":-2.137877,"median":-0.879672,"eighty":-0.457148,"marketCap":32427442},{"date":"2024-04-26","current":-1.223965,"twenty":-2.098382,"median":-0.879938,"eighty":-0.457233,"marketCap":34824253},{"date":"2024-05-03","current":-1.238831,"twenty":-2.057937,"median":-0.879938,"eighty":-0.457233,"marketCap":35247220},{"date":"2024-05-10","current":-1.284847,"twenty":-2.021354,"median":-0.879938,"eighty":-0.457233,"marketCap":37362053},{"date":"2024-05-17","current":-1.309089,"twenty":-2.016513,"median":-0.879938,"eighty":-0.457233,"marketCap":38066997},{"date":"2024-05-24","current":-1.27515,"twenty":-2.00909,"median":-0.879938,"eighty":-0.457233,"marketCap":37080075},{"date":"2024-05-31","current":-1.269017,"twenty":-1.990082,"median":-0.879938,"eighty":-0.457233,"marketCap":36901747},{"date":"2024-06-07","current":-1.124129,"twenty":-1.960297,"median":-0.879938,"eighty":-0.457233,"marketCap":32688555},{"date":"2024-06-14","current":-1.14911,"twenty":-1.931817,"median":-0.879938,"eighty":-0.457233,"marketCap":33414968},{"date":"2024-06-21","current":-0.909296,"twenty":-1.915649,"median":-0.876192,"eighty":-0.457148,"marketCap":26441409},{"date":"2024-06-28","current":-0.984238,"twenty":-1.833939,"median":-0.869493,"eighty":-0.457148,"marketCap":28620646},{"date":"2024-07-05","current":-0.919288,"twenty":-1.768011,"median":-0.869493,"eighty":-0.457148,"marketCap":26731974},{"date":"2024-07-12","current":-1.069172,"twenty":-1.729878,"median":-0.869493,"eighty":-0.457148,"marketCap":31090448},{"date":"2024-07-19","current":-1.064176,"twenty":-1.713082,"median":-0.869493,"eighty":-0.457148,"marketCap":30945166},{"date":"2024-07-26","current":-1.044191,"twenty":-1.691942,"median":-0.869493,"eighty":-0.457148,"marketCap":30364036},{"date":"2024-08-02","current":-0.899303,"twenty":-1.629045,"median":-0.869493,"eighty":-0.457148,"marketCap":26150844},{"date":"2024-08-09","current":-0.814369,"twenty":-1.567382,"median":-0.869219,"eighty":-0.457148,"marketCap":23681042},{"date":"2024-08-16","current":-0.965064,"twenty":-1.540943,"median":-0.868547,"eighty":-0.457148,"marketCap":27433878},{"date":"2024-08-23","current":-0.970253,"twenty":-1.520623,"median":-0.868547,"eighty":-0.457148,"marketCap":27581372},{"date":"2024-08-30","current":-0.94431,"twenty":-1.494812,"median":-0.868547,"eighty":-0.457148,"marketCap":26843902},{"date":"2024-09-06","current":-0.985818,"twenty":-1.484233,"median":-0.868547,"eighty":-0.457148,"marketCap":28023854},{"date":"2024-09-13","current":-0.954687,"twenty":-1.452543,"median":-0.868547,"eighty":-0.457148,"marketCap":27138890},{"date":"2024-09-20","current":-1.032515,"twenty":-1.415536,"median":-0.868547,"eighty":-0.457148,"marketCap":29351300},{"date":"2024-09-27","current":-0.954687,"twenty":-1.402357,"median":-0.868547,"eighty":-0.457148,"marketCap":27138890},{"date":"2024-10-04","current":-0.98063,"twenty":-1.389837,"median":-0.868547,"eighty":-0.457148,"marketCap":27876360},{"date":"2024-10-11","current":-0.991007,"twenty":-1.375376,"median":-0.868547,"eighty":-0.457148,"marketCap":28171348},{"date":"2024-10-18","current":-1.149256,"twenty":-1.36134,"median":-0.868547,"eighty":-0.457148,"marketCap":32669914},{"date":"2024-10-25","current":-1.385334,"twenty":-1.348338,"median":-0.868547,"eighty":-0.457148,"marketCap":39380889},{"date":"2024-11-01","current":-1.374957,"twenty":-1.348338,"median":-0.868547,"eighty":-0.457148,"marketCap":39085902},{"date":"2024-11-08","current":-1.371016,"twenty":-1.348338,"median":-0.868547,"eighty":-0.457148,"marketCap":46614528},{"date":"2024-11-15","current":-1.171437,"twenty":-1.340253,"median":-0.868547,"eighty":-0.457148,"marketCap":39828869},{"date":"2024-11-22","current":-1.314613,"twenty":-1.312877,"median":-0.868547,"eighty":-0.457148,"marketCap":44696841},{"date":"2024-11-29","current":-1.284242,"twenty":-1.302589,"median":-0.868547,"eighty":-0.457148,"marketCap":43664241},{"date":"2024-12-06","current":-1.16276,"twenty":-1.294281,"median":-0.868547,"eighty":-0.457148,"marketCap":39533840},{"date":"2024-12-13","current":-1.110696,"twenty":-1.282507,"median":-0.868547,"eighty":-0.457148,"marketCap":37763668},{"date":"2024-12-20","current":-1.084664,"twenty":-1.273815,"median":-0.868547,"eighty":-0.457148,"marketCap":36878582},{"date":"2024-12-27","current":-1.375354,"twenty":-1.273518,"median":-0.868547,"eighty":-0.457148,"marketCap":46762042},{"date":"2025-01-03","current":-1.501175,"twenty":-1.273518,"median":-0.868547,"eighty":-0.457148,"marketCap":51039958},{"date":"2025-01-10","current":-1.488159,"twenty":-1.273484,"median":-0.867787,"eighty":-0.457063,"marketCap":50597415},{"date":"2025-01-17","current":-1.171437,"twenty":-1.263727,"median":-0.867787,"eighty":-0.457063,"marketCap":39828869},{"date":"2025-01-24","current":-1.197469,"twenty":-1.25332,"median":-0.867787,"eighty":-0.457063,"marketCap":40713955},{"date":"2025-01-31","current":-1.019584,"twenty":-1.245244,"median":-0.867787,"eighty":-0.457063,"marketCap":34665867},{"date":"2025-02-07","current":-1.045616,"twenty":-1.231679,"median":-0.867787,"eighty":-0.457063,"marketCap":35550953},{"date":"2025-02-14","current":-1.071648,"twenty":-1.223872,"median":-0.867787,"eighty":-0.457063,"marketCap":36436039},{"date":"2025-02-21","current":-1.188792,"twenty":-1.205789,"median":-0.867787,"eighty":-0.457063,"marketCap":40418926},{"date":"2025-02-28","current":-1.093341,"twenty":-1.201515,"median":-0.867787,"eighty":-0.457063,"marketCap":37173611},{"date":"2025-03-07","current":-0.815327,"twenty":-1.197469,"median":-0.864331,"eighty":-0.456978,"marketCap":32477728},{"date":"2025-03-14","current":-0.688746,"twenty":-1.193131,"median":-0.862718,"eighty":-0.456978,"marketCap":27435524},{"date":"2025-03-21","current":-0.640348,"twenty":-1.187341,"median":-0.858313,"eighty":-0.456978,"marketCap":25507622},{"date":"2025-03-28","current":-0.632902,"twenty":-1.180115,"median":-0.84947,"eighty":-0.456978,"marketCap":25211022},{"date":"2025-04-04","current":-0.580781,"twenty":-1.171437,"median":-0.842654,"eighty":-0.456978,"marketCap":23134820},{"date":"2025-04-11","current":-0.578919,"twenty":-1.171437,"median":-0.840996,"eighty":-0.457063,"marketCap":23060670},{"date":"2025-04-17","current":-0.688746,"twenty":-1.171437,"median":-0.834445,"eighty":-0.457063,"marketCap":27435524},{"date":"2025-04-25","current":-0.532382,"twenty":-1.171437,"median":-0.827672,"eighty":-0.456978,"marketCap":21206918},{"date":"2025-05-02","current":-0.510045,"twenty":-1.171437,"median":-0.821914,"eighty":-0.456978,"marketCap":20317117},{"date":"2025-05-09","current":-0.513422,"twenty":-1.171437,"median":-0.815327,"eighty":-0.456978,"marketCap":21664359},{"date":"2025-05-16","current":-0.481827,"twenty":-1.164501,"median":-0.810339,"eighty":-0.456978,"marketCap":20331168},{"date":"2025-05-23","current":-0.39494,"twenty":-1.154591,"median":-0.80603,"eighty":-0.454046,"marketCap":16664892},{"date":"2025-05-30","current":-0.381117,"twenty":-1.149398,"median":-0.798597,"eighty":-0.449032,"marketCap":16081620},{"date":"2025-06-06","current":-0.39494,"twenty":-1.145405,"median":-0.792959,"eighty":-0.443884,"marketCap":16664892},{"date":"2025-06-13","current":-0.351418,"twenty":-1.139118,"median":-0.790781,"eighty":-0.441268,"marketCap":14828420},{"date":"2025-06-20","current":-0.371402,"twenty":-1.131159,"median":-0.784338,"eighty":-0.437293,"marketCap":15671664}],"updateTime":1750727688884}}}